130 related articles for article (PubMed ID: 35385803)
21. Twenty Crystal Structures of Bromodomain and PHD Finger Containing Protein 1 (BRPF1)/Ligand Complexes Reveal Conserved Binding Motifs and Rare Interactions.
Zhu J; Caflisch A
J Med Chem; 2016 Jun; 59(11):5555-61. PubMed ID: 27167503
[TBL] [Abstract][Full Text] [Related]
22. GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain.
Bamborough P; Barnett HA; Becher I; Bird MJ; Chung CW; Craggs PD; Demont EH; Diallo H; Fallon DJ; Gordon LJ; Grandi P; Hobbs CI; Hooper-Greenhill E; Jones EJ; Law RP; Le Gall A; Lugo D; Michon AM; Mitchell DJ; Prinjha RK; Sheppard RJ; Watson AJ; Watson RJ
ACS Med Chem Lett; 2016 Jun; 7(6):552-7. PubMed ID: 27326325
[TBL] [Abstract][Full Text] [Related]
23. Isoform-specific involvement of Brpf1 in expansion of adult hematopoietic stem and progenitor cells.
He Q; Hong M; He J; Chen W; Zhao M; Zhao W
J Mol Cell Biol; 2020 Jun; 12(5):359-371. PubMed ID: 31565729
[TBL] [Abstract][Full Text] [Related]
24. Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.
Romero FA; Taylor AM; Crawford TD; Tsui V; Côté A; Magnuson S
J Med Chem; 2016 Feb; 59(4):1271-98. PubMed ID: 26572217
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological targeting of Tripartite Motif Containing 24 for the treatment of glioblastoma.
Han M; Sun Y
J Transl Med; 2021 Dec; 19(1):505. PubMed ID: 34886858
[TBL] [Abstract][Full Text] [Related]
26. Expression atlas of the multivalent epigenetic regulator Brpf1 and its requirement for survival of mouse embryos.
You L; Chen L; Penney J; Miao D; Yang XJ
Epigenetics; 2014 Jun; 9(6):860-72. PubMed ID: 24646517
[TBL] [Abstract][Full Text] [Related]
27. Molecular Basis for the PZP Domain of BRPF1 Association with Chromatin.
Klein BJ; Cox KL; Jang SM; Côté J; Poirier MG; Kutateladze TG
Structure; 2020 Jan; 28(1):105-110.e3. PubMed ID: 31711755
[TBL] [Abstract][Full Text] [Related]
28. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I
Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712
[TBL] [Abstract][Full Text] [Related]
29. Computational studies with flavonoids and terpenoids as BRPF1 inhibitors: in silico biological activity prediction, molecular docking, molecular dynamics simulations, MM/PBSA calculations.
Yalçin-Özkat G
SAR QSAR Environ Res; 2022 Jul; 33(7):533-550. PubMed ID: 35822928
[TBL] [Abstract][Full Text] [Related]
30. Deficient histone H3 propionylation by BRPF1-KAT6 complexes in neurodevelopmental disorders and cancer.
Yan K; Rousseau J; Machol K; Cross LA; Agre KE; Gibson CF; Goverde A; Engleman KL; Verdin H; De Baere E; Potocki L; Zhou D; Cadieux-Dion M; Bellus GA; Wagner MD; Hale RJ; Esber N; Riley AF; Solomon BD; Cho MT; McWalter K; Eyal R; Hainlen MK; Mendelsohn BA; Porter HM; Lanpher BC; Lewis AM; Savatt J; Thiffault I; Callewaert B; Campeau PM; Yang XJ
Sci Adv; 2020 Jan; 6(4):eaax0021. PubMed ID: 32010779
[TBL] [Abstract][Full Text] [Related]
31. The chromatin regulator Brpf1 regulates embryo development and cell proliferation.
You L; Yan K; Zou J; Zhao H; Bertos NR; Park M; Wang E; Yang XJ
J Biol Chem; 2015 May; 290(18):11349-64. PubMed ID: 25773539
[TBL] [Abstract][Full Text] [Related]
32. Exploring the chemical space of functionalized [1,2,4]triazolo[4,3-a]quinoxaline-based compounds targeting the bromodomain of BRD9.
Gazzillo E; Pierri M; Colarusso E; Chini MG; Ferraro MG; Piccolo M; Irace C; Bruno I; Bifulco G; Terracciano S; Lauro G
Bioorg Chem; 2023 Oct; 139():106677. PubMed ID: 37352721
[TBL] [Abstract][Full Text] [Related]
33. TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.
Groner AC; Cato L; de Tribolet-Hardy J; Bernasocchi T; Janouskova H; Melchers D; Houtman R; Cato ACB; Tschopp P; Gu L; Corsinotti A; Zhong Q; Fankhauser C; Fritz C; Poyet C; Wagner U; Guo T; Aebersold R; Garraway LA; Wild PJ; Theurillat JP; Brown M
Cancer Cell; 2016 Jun; 29(6):846-858. PubMed ID: 27238081
[TBL] [Abstract][Full Text] [Related]
34. Tripartite motif containing 24 regulates cell proliferation in colorectal cancer through YAP signaling.
Xie W; Zhang Y; Wang B; Hu Y; Zhan B; Wei F; Tang J; Lian J
Cancer Med; 2020 Sep; 9(17):6367-6376. PubMed ID: 32677374
[TBL] [Abstract][Full Text] [Related]
35. Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer.
Zou LJ; Xiang QP; Xue XQ; Zhang C; Li CC; Wang C; Li Q; Wang R; Wu S; Zhou YL; Zhang Y; Xu Y
Acta Pharmacol Sin; 2019 Nov; 40(11):1436-1447. PubMed ID: 31097763
[TBL] [Abstract][Full Text] [Related]
36. Discovery of a potent and selective CBP bromodomain inhibitor (Y08262) for treating acute myeloid leukemia.
Xiang Q; Wu T; Zhang C; Wang C; Xu H; Hu Q; Hu J; Luo G; Zhuang X; Wu X; Zhang Y; Xu Y
Bioorg Chem; 2024 Jan; 142():106950. PubMed ID: 37924753
[TBL] [Abstract][Full Text] [Related]
37. TRIM24 links a non-canonical histone signature to breast cancer.
Tsai WW; Wang Z; Yiu TT; Akdemir KC; Xia W; Winter S; Tsai CY; Shi X; Schwarzer D; Plunkett W; Aronow B; Gozani O; Fischle W; Hung MC; Patel DJ; Barton MC
Nature; 2010 Dec; 468(7326):927-32. PubMed ID: 21164480
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer.
Shi SJ; Wang LJ; Han DH; Wu JH; Jiao D; Zhang KL; Chen JW; Li Y; Yang F; Zhang JL; Zheng GX; Yang AG; Zhao AZ; Qin WJ; Wen WH
Theranostics; 2019; 9(5):1247-1263. PubMed ID: 30867828
[No Abstract] [Full Text] [Related]
39. Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery.
Zhan Y; Kost-Alimova M; Shi X; Leo E; Bardenhagen JP; Shepard HE; Appikonda S; Vangamudi B; Zhao S; Tieu TN; Jiang S; Heffernan TP; Marszalek JR; Toniatti C; Draetta G; Tyler J; Barton M; Jones P; Palmer WS; Geck Do MK; Andersen JN
Epigenetics Chromatin; 2015; 8():37. PubMed ID: 26396593
[TBL] [Abstract][Full Text] [Related]
40. TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression.
Fong KW; Zhao JC; Song B; Zheng B; Yu J
Nat Commun; 2018 Nov; 9(1):5007. PubMed ID: 30479348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
